Association of Ets-related transcriptional factor E1AF expression with overexpression of matrix metalloproteinases, COX-2 and iNOS in the early stage of colorectal carcinogenesis

Carcinogenesis

Volumn 26, Issue 5, 2005, Pages 892-899

  Nosho, Katsuhiko ^a   Yoshida, Mio ^a   Yamamoto, Hiroyuki ^a   Taniguchi, Hiroaki ^a   Adachi, Yasushi ^a   Mikami, Masashi ^a   Hinoda, Yuji ^b   Imai, Kohzoh ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

^b YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERSTITIAL COLLAGENASE; MATRILYSIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E1AF; UNCLASSIFIED DRUG; E1A PROTEIN; ETV4 PROTEIN, HUMAN; MATRIX METALLOPROTEINASE; MEMBRANE PROTEIN; MESSENGER RNA; NITRIC OXIDE SYNTHASE; NOS2A PROTEIN, HUMAN; ONCOPROTEIN; PROSTAGLANDIN SYNTHASE; PTGS2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR ETS;

ADULT; AGED; ARTICLE; COLON CARCINOGENESIS; COLON MUCOSA; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; TUMOR VOLUME; BIOSYNTHESIS; COLORECTAL TUMOR; ENZYMOLOGY; GENETICS; METABOLISM;

ADENOVIRUS E1A PROTEINS; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASES; MEMBRANE PROTEINS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 19844380348     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgi029     Document Type: Article

References (36)

1. Jass, J.R., Whitehall, V.L., Young, J. and Leggett, B.A. (2002) Emerging concepts in colorectal neoplasia. Gastroenterology, 123, 862-876.
2. Chambers, A.F. and Matrisian, L.M. (1997) Changing views of the role of matrix metalloproteinases in metastasis. J. Natl Cancer Inst., 89, 1260-1270.
3. Nelson, A.R., Fingleton, B. Rothenberg, M.L. and Matrisian, L.M. (2000) Matrix metalloproteinases: biologic activity and clinical implications. J. Clin. Oncol., 18, 1135-1149.
4. Overall, C.M. and Lopez-Otin, C. (2002) Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nature Rev. Cancer., 2, 657-672.
5. Stamenkovic, I. (2003) Extracellular matrix remodelling: the role of matrix metalloproteinases. J. Pathol., 200, 448-464.
6. Leeman, M.F., Curran, S. and Murray, G.I. (2003) New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression. J. Pathol., 201, 528-534.
7. Zucker, S. and Vacirca, J. (2004) Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev., 23, 101-117.
8. Wagenaar-Miller, R.A., Gorden, L. and Matrisian, L.M. (2004) Matrix metalloproteinases in colorectal cancer: Is it worth talking about? Cancer Metastasis Rev., 23, 119-135.
9. Gearing, A.J., Beckett, P., Christodoulou, M., Churchill, M., Clements, J., Davidson, A.H., Drummond, A.H., Galloway, W.A., Gilbert, R. and Gordon, J.L. (1994) Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature, 370, 555-557.
10. Kayagaki, N., Kawasaki, A., Ebata, T., Ohmoto, H., Ikeda, S., Inoue, S., Yoshino, K., Okumura, K. and Yagita, H. (1995) Metalloproteinase-mediated release of human Fas ligand. J. Exp. Med., 182, 1777-1783.
11. Manes, S., Llorente, M., Lacalle, R.A., Gomez-Mouton, C., Kremer, L., Mira, E. and Martinez, A.C. (1999) The matrix metalloproteinase-9 regulates the insulin-like growth factor-triggered autocrine response in DU-145 carcinoma cells. J. Biol. Chem., 274, 6935-6945.
12. Urbanski, S.J., Edwards, D.R., Hershfield, N., Huchcroft, S.A., Shaffer, E., Sutherland, L. and Kossakowska, A.E. (1993) Expression pattern of metalloproteinases and their inhibitors changes with the progression of human sporadic colorectal neoplasia. Diagn. Mol. Pathol., 2, 81-89.
13. Newell, K.J., Witty, J.P., Rodgers, W.H. and Matrisian, L.M. (1994) Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis. Mol. Carcinog., 10, 199-206.
14. Yamamoto, H., Itoh, F., Hinoda, Y., Senota, A., Yoshimoto, M., Nakamura, H., Imai, K. and Yachi, A. (1994) Expression of matrilysin mRNA in colorectal adenomas and its induction by truncated fibronectin. Biochem. Biophys. Res. Commun., 201, 657-664.
15. Tomita, T. and Iwata, K. (1996) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in colonic adenomas-adenocarcinomas. Dis. Colon Rectum, 39, 1255-1264.
16. Takeuchi, N., Ichikawa, Y., Ishikawa, T., Momiyama, N., Hasegawa, S., Nagashima, Y., Miyazaki, K., Koshikawa, N., Mitsuhashi, M. and Shimada, H. (1997) Matrilysin gene expression in sporadic and familial colorectal adenomas. Mol. Carcinog., 19, 225-229.
17. Heslin, M.J., Yan, J., Johnson, M.R., Weiss, H., Diasio, R.B., and Urist, M.M. (2001) Role of matrix metalloproteinases in colorectal carcinogenesis. Ann. Surg., 233, 786-792.
18. Wilson, C.L., Heppner, K.J., Labosky, P.A., Hogan, B.L. and Matrisian, L.M. (1997) Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc. Natl Acad. Sci. USA, 94, 1402-1407.
19. Horiuchi, S., Yamamoto, H., Min, Y., Adachi, Y., Itoh, F. and Imai, K. (2003) Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer. J. Pathol., 200, 568-576.
20. Howe, L.R., Crawford, H.C., Subbaramaiah, K., Hassell, J.A., Dannenberg, A.J. and Brown, A.M. (2001) PEA3 is up-regulated in response to Wnt1 and activates the expression of cyclooxygenase-2. J. Biol. Chem., 276, 20108-20115.
21. Williams, C., Shattuck-Brandt, R.L. and DuBois, R.N. (1999) The role of COX-2 in intestinal cancer. Ann. NY Acad. Sci., 889, 72-83.
22. Williams, C.S., Mann, M. and DuBois, R.N. (1999) The role of cyclooxygenases in inflammation, cancer, and development. Oncogene, 18, 7908-7916.
23. Prescott, S.M. and Fitzpatrick, F.A. (2000) Cyclooxygenase-2 and carcinogenesis. Biochim. Biophys. Acta, 1470, M69-78.
24. Stack, E. and DuBois, R.N. (2001) Regulation of cyclo-oxygenase-2. Best Pract. Res. Clin. Gastroenterol., 15, 787-800.
25. Einspahr, J.G., Krouse, R.S., Yochim, J.M., Danenberg, P.V., Danenberg, K.D., Bhattacharyya, A.K., Martinez, M.E. and Alberts, D.S. (2003) Association between cyclooxygenase expression and colorectal adenoma characteristics. Cancer Res., 63, 3891-3893.
26. Araki, Y., Okamura, S., Hussain, S.P., Nagashima, M., He, P., Shiseki, M., Miura, K. and Harris, C.C. (2003) Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways. Cancer Res., 63, 728-734.
27. Jenkins, D.C., Charles, I.G., Thomsen, L.L., Moss, D.W., Holmes, L.S., Baylis, S.A., Rhodes, P., Westmore, K., Emson, P.C. and Moncada, S. (1995) Roles of nitric oxide in tumor growth. Proc. Natl Acad. Sci. USA, 92, 4392-4396.
28. Cianchi, F., Cortesini, C., Bechi, P., Fantappie, O., Messerini, L., Vannacci, A., Sardi, I., Baroni, G., Boddi, V., Mazzanti, R. and Masini, E. (2001) Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer. Gastroenterology, 121, 1339-1347.
29. Cianchi, F., Cortesini, C., Fantappie, O., Messerini, L., Schiavone, N., Vannacci, A., Nistri, S., Sardi, I., Baroni, G., Marzocca, C., Perna, F., Mazzanti, R., Bechi, P. and Masini, E. (2003) Inducible nitric oxide synthase expression in human colorectal cancer: correlation with tumor angiogenesis. Am. J. Pathol., 162, 793-801.
30. Liu, Y., Borchert, G.L. and Phang, J.M. (2004) Polyoma enhancer activator 3, an ets transcription factor, mediates the induction of cyclooxygenase-2 by nitric oxide in colorectal cancer cells. J. Biol. Chem., 279, 18694-18700.
31. Benz, C.C., O'Hagan, R.C., Richter, B., Scott, G.K., Chang, C.H., Xiong, X., Chew, K., Ljung, B.M., Edgerton, S., Thor, A. and Hassell, J.A. (1997) HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer. Oncogene, 15, 1513-1525.
32. Crawford, H.C., Fingleton, B., Gustavson, M.D., Kurpios, N., Wagenaar, R.A., Hassell, J.A. and Matrisian, L.M. (2001) The PEA3 subfamily of Ets transcription factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors. Mol. Cell. Biol., 21, 1370-1383.
33. Shao, J., Sheng, H., Inoue, H., Morrow, J.D. and DuBois, R.N. (2000) Regulation of constitutive cyclooxygenase-2 expression in colon carcinoma cells. J. Biol. Chem., 275, 33951-33956.
34. Kutchera, W., Jones, D.A., Matsunami, N., Groden, J., McIntyre, T.M., Zimmerman, G.A., White, R.L. and Prescott, S.M. (1996) Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. Proc. Natl Acad. Sci. USA, 93, 4816-4820.
35. Yagihashi, N., Kasajima, H., Sugai, S., Matsumoto, K., Ebina, Y., Morita, T., Murakami, T. and Yagihashi, S. (2000) Increased in situ expression of nitric oxide synthase in human colorectal cancer. Virchows Arch., 436, 109-114.
36. Wagenaar-Miller, R.A., Hanley, G., Shattuck-Brandt, R., DuBois, R.N., Bell, R.L., Matrisian, L.M. and Morgan, D.W. (2003) Cooperative effects of matrix metalloproteinase and cyclooxygenase-2 inhibition on intestinal adenoma reduction. Br. J. Cancer, 88, 1445-1452.